$EVER

EverQuote (EVER) Q3 2026 Earnings Call Transcript

EverQuote (EVER) reported Q3 2026 earnings, exceeding guidance with 25% revenue growth to $218.1M and 41% adjusted EBITDA growth to $35.5M. The company highlighted strong performance in home insurance (70% YoY growth) and AI-driven initiatives, including new AI-native platforms and partnerships. The board authorized a $50M share repurchase program. Q4 2026 guidance projects 12% revenue growth.

Original reporting
Published Nov 3, 2026, 4:28 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:37 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
EverQuote (EVER) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$EVERBullishHigh
01

Why it matters

The earnings beat and guidance expansion are likely to attract buying interest, especially given the company's AI initiatives and debt‑free balance sheet.

02

Market read

First‑report earnings with strong top‑line growth and new buyback provide a clear catalyst for short‑term price movement.

03

What to watch

One‑time termination fee and higher tax expense reduced GAAP net income; cash flow quality and debt‑free balance sheet merit close monitoring.

Relevance 7/10Novelty 8/10Timing: immediate post‑earnings today

Background

EverQuote disclosed its Q3 2026 financial results and forward guidance, including a new $50M share repurchase program.

Company-level read

Ticker impact

$EVERBullishHigh confidence
Context

Q3 2026 earnings released with revenue $218.1M, 25% growth and adjusted EBITDA up 41% YoY, beating the high end of guidance.

Expected impact

likely upward pressure as investors price in better-than-expected results and new share repurchase program

Evidence & confidence

Results exceed guidance, revenue growth accelerates, and a $50M buyback was authorized, all fresh data driving demand.

Market effects

Highlights growth potential in AI‑enabled P&C insurance distribution, may boost peer sentiment in insurtech sector.

U.S. insurtech and AI‑driven fintech stocks could see modest gains.

Demonstrates viable AI monetization in insurance, relevant for global insurers exploring similar tech.

Counterpoint

If AI rollout costs rise or integration delays occur, the earnings beat may be short‑lived and valuation could be overstretched.

Key entities

  • EverQuote

    U.S. insurtech firm (ticker EVER) reporting Q3 earnings.

Related articles

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.

$EVERMed

What EverQuote (EVER) Said on Its Q3 Earnings Call

EverQuote (EVER) reported Q3 operating cash flow of $40.5M, $229.1M in cash, and no debt. The board approved a $50M share buyback program. The company highlighted AI initiatives, including SmartCampaigns and the launch of Luva, an AI-native insurance platform. For Q4, EverQuote expects revenue of $213M-$223M, variable marketing dollars of $57M-$60M, and adjusted EBITDA of $29M-$32M, with a long-term goal of $1B in annual revenue.